Brexanolone (Zulresso): Finally, an FDA-Approved Treatment for Postpartum Depression

Pharmacotherapy of Postpartum Depression: Current Approaches and Novel Drug Development

(2019) Ariela Frieder et al.   CNS DRUGS

Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials

(2018) Samantha Meltzer-Brody et al.   LANCET

Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial

(2017) Stephen Kanes et al.   LANCET

Trends in Postpartum Depressive Symptoms — 27 States, 2004, 2008, and 2012

(2017) Jean Y. Ko et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

All-Cause Mortality in Women With Severe Postpartum Psychiatric Disorders

(2016) Benedicte Marie Winther Johannsen et al.   AMERICAN JOURNAL OF PSYCHIATRY

The Hamilton Rating Scale for Depression

(2015) Rachel Sharp   OCCUPATIONAL MEDICINE-OXFORD

The Columbia–Suicide Severity Rating Scale: Initial Validity and Internal Consistency Findings From Three Multisite Studies With Adolescents and Adults

(2011) Kelly Posner et al.   AMERICAN JOURNAL OF PSYCHIATRY

Identification of Postpartum Depression

(2009) DOROTHY K. Y. SIT et al.   CLINICAL OBSTETRICS AND GYNECOLOGY